TC BIOPHARM (HOLDINGS) PLC: interest_expense
| Value | {"unit": "GBP", "value": 83025, "concept": "us-gaap:InterestExpenseNonoperating"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | TC BIOPHARM (HOLDINGS) PLC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:48:08.572556+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8480860c-d83e-48fe-9c34-80e68c7a6a90
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001641172-25-009445Retrieved: 2026-08-19T18:48:08.572556+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001872812/interest-expense/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8480860c-d83e-48fe-9c34-80e68c7a6a90
History
- supersedes {"unit": "GBP", "value": 83025, "concept": "us-gaap:InterestExpense"} (evidence 0001493152-24-012486)